Methotrexate in recurrent postpericardiotomy syndrome

Cardiol Young. 2003 Apr;13(2):206-8. doi: 10.1017/s1047951103000404.

Abstract

The postpericardiotomy syndrome occurs in up to one-third of children undergoing cardiac surgery. Its treatment includes anti-inflammatory agents, diuresis, and drainage of effusions. Administration of steroids can have a dramatic effect, but is limited by adverse effects. Usually the syndrome lasts weeks only, and persistence beyond six months is exceptional. We describe a rare case of chronic postpericardiotomy syndrome, with recurrent pericardial effusions and steroid dependency, that was treated successfully with a low weekly dose of methotrexate.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Child
  • Humans
  • Male
  • Methotrexate / therapeutic use*
  • Postpericardiotomy Syndrome / drug therapy*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Methotrexate